Page last updated: 2024-11-04

gatifloxacin and Adenoma, beta-Cell

gatifloxacin has been researched along with Adenoma, beta-Cell in 1 studies

Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.

Research Excerpts

ExcerptRelevanceReference
"Gatifloxacin can cause both hypoglycemia and hyperglycemia in both diabetic and non-diabetic patients."1.33Gatifloxacin acutely stimulates insulin secretion and chronically suppresses insulin biosynthesis. ( Inagaki, N; Kawasaki, Y; Nagashima, K; Seino, Y; Takahashi, A; Ueno, H; Yamada, C; Yamada, Y, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yamada, C1
Nagashima, K1
Takahashi, A1
Ueno, H1
Kawasaki, Y1
Yamada, Y1
Seino, Y1
Inagaki, N1

Other Studies

1 other study available for gatifloxacin and Adenoma, beta-Cell

ArticleYear
Gatifloxacin acutely stimulates insulin secretion and chronically suppresses insulin biosynthesis.
    European journal of pharmacology, 2006, Dec-28, Volume: 553, Issue:1-3

    Topics: Animals; Anti-Infective Agents; Blood Glucose; Cell Line, Tumor; Cell Separation; Fluoroquinolones;

2006